Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1990-03-15
1992-12-15
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, 424 854, A61K 4502
Patent
active
051715678
ABSTRACT:
An improved method for treating or curing ATL, with lowered side effects, comprising administering an effective amount of interferon-.gamma. to a mammalian species in need of such treatment via respiratory tract by inhalation, wherein recommended is that a single dose of said interferon-.gamma. to human adults is 1,000,000 JRU to 6,000,000 JRU and the single dose is repeated at a frequency between once-a-week and twice-a-day.
REFERENCES:
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4659570 (1987-04-01), Terano
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4851219 (1989-07-01), Sherwin
patent: 4895716 (1990-01-01), Goldstein et al.
patent: 4985242 (1991-01-01), Sekine et al.
Tamura et al. in Cancer, vol. 59, pp. 1059-1062 (1987).
English Abstract of presentation by Dr. Tara, at a medical conference. Japanese presentation published in Rinsho to Kenkyuu, vol. 68, pp. 2761 to 2765 (1991).
Medline Abstract No. 90065143, J. Nakayama et al., "Cutaneous Lesion of Adult T-Cell Lymphoma Treated Successfully With Local Hyperthermia . . . " & Nippon Hifuka Gakkai Zasshi, Jul. 1989, vol. 99, No. 8, pp. 907-914.
Biological Abstract No. 83120094, K. Tamura et al., "Recombinant Interferon Beta and Gamma in the Treatment of Adult T-Cell Leukemia" & Cancer, vol. 59, No. 6, 1987, pp. 1059-1062.
Schain Howard E.
Shionogi & Co. Ltd.
LandOfFree
Method for the treatment of ATLL and the inhalant for the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of ATLL and the inhalant for the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of ATLL and the inhalant for the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2091439